What kind of drug is everolimus?

Everolimus is an immunosuppressant and a targeted therapy. It affects cell growth, division and metabolism by inhibiting the activity of the mammalian target of rapamycin (mTOR) signaling pathway. The drug may be used in a variety of clinical situations, including immunosuppression after organ transplantation, treatment of certain types of breast cancer and neuroendocrine tumors, and treatment of meningiomas associated with tuberous sclerosis complex (TSC). Everolimus' mechanism of action enables it to target specific molecular targets in cancer and other diseases, thereby interfering with the growth and spread of abnormal cells and achieving therapeutic effects. However, the use of everolimus must be done under the guidance of a professional doctor, as it may be associated with some side effects that require treatment under medical supervision.